Form 4 Filing for Jennifer L. Davis - AbbVie Inc.

Jennifer L. Davis, a director at AbbVie Inc. (ABBV), acquired 1118 restricted stock units on May 8, 2026. These units, awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program, will convert to common stock on a one-to-one basis upon her separation from service, death, or a change in control. Following this transaction, Ms. Davis now holds 3643 shares. The acquisition was reported on a Form 4 filing submitted on May 12, 2026.